203 related articles for article (PubMed ID: 31942465)
1. Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia.
Chung JS; Seo WI; Oh CK; Kim SC; Park MC; Park SH; Yu J; Lee CH; Kim W; Park TY; Min KS; Chung JI
Investig Clin Urol; 2020 Jan; 61(1):67-74. PubMed ID: 31942465
[TBL] [Abstract][Full Text] [Related]
2. Thulium laser (RevoLix) vaporesection versus vapoenucleation with morcellator (Piranha) for the treatment of benign prostatic obstruction: a propensity-matched multicenter analysis.
Chung JS; Kang PM; Seo WI; Oh CK; Kim SC; Park SH; Choi JH; Yoon JH; Kang DI; Chung JI
Int J Urol; 2014 Nov; 21(11):1156-61. PubMed ID: 25040293
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.
Hong K; Liu YQ; Lu J; Xiao CL; Huang Y; Ma LL
Chin Med J (Engl); 2015 Apr; 128(7):884-9. PubMed ID: 25836607
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
[TBL] [Abstract][Full Text] [Related]
5. Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size determine adverse surgical outcome.
Rausch S; Heider T; Bedke J; Kruck S; Schwentner C; Fischer K; Stenzl A; Kälble T
Urology; 2015 Jan; 85(1):182-8. PubMed ID: 25530383
[TBL] [Abstract][Full Text] [Related]
6. Transurethral vaporesection of prostate: diode laser or thulium laser?
Tan X; Zhang X; Li D; Chen X; Dai Y; Gu J; Chen M; Hu S; Bai Y; Ning Y
Lasers Med Sci; 2018 May; 33(4):891-897. PubMed ID: 29633057
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic vaporesection of the prostate using the continuous-wave 2-microm thulium laser: outcome and demonstration of the surgical technique.
Szlauer R; Götschl R; Razmaria A; Paras L; Schmeller NT
Eur Urol; 2009 Feb; 55(2):368-75. PubMed ID: 19022557
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 120-200 W 2 μm thulium:yttrium-aluminum-garnet vapoenucleation of the prostate.
Netsch C; Bach T; Pohlmann L; Herrmann T; Gross AJ
J Endourol; 2012 Mar; 26(3):224-9. PubMed ID: 22191688
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and efficiency of Green-Light XPS 180-watt laser system for benign prostatic enlargement in patients treated with 5α-reductase inhibitors.
Ghahhari J; De Nunzio C; Lombardo R; Tubaro A; Brassetti A; De Francesco P; Schips L; Cindolo L
Eur Rev Med Pharmacol Sci; 2021 Jul; 25(13):4527-4534. PubMed ID: 34286495
[TBL] [Abstract][Full Text] [Related]
10. Thulium laser vaporesection versus transurethral electrovaporization of the prostate in high-risk patients with benign prostatic hyperplasia.
Zhu Z; Shen Z; Tu F; Zhu Y; Sun F; Shao Y; Wang H; Zhong S; Xu C
Photomed Laser Surg; 2012 Dec; 30(12):714-8. PubMed ID: 23113512
[TBL] [Abstract][Full Text] [Related]
11. The RevoLix 2 micron continuous wave laser vaporesection for the treatment of high-risk patients with benign prostatic hyperplasia.
Si J; Gu B; Yu J; Xu Y
Photomed Laser Surg; 2011 Feb; 29(2):105-7. PubMed ID: 21182453
[TBL] [Abstract][Full Text] [Related]
12. Transurethral thulium laser enucleation versus resection of the prostate for treating benign prostatic hyperplasia: a retrospective study.
Yuan R; Boyu Y; Fujun Z; Chengyi J; Yifeng J; Xiaohai W; Di C; Shujie X; Bangmin H
Lasers Med Sci; 2019 Mar; 34(2):329-334. PubMed ID: 30109535
[TBL] [Abstract][Full Text] [Related]
13. Thulium Vaporesection of the Prostate and Thulium Vapoenucleation of the Prostate: A Retrospective Bicentric Matched-Paired Comparison with 24-Month Follow-Up.
Becker B; Buttice S; Magno C; Gross AJ; Netsch C
Urol Int; 2018; 100(1):105-111. PubMed ID: 29186715
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates.
Wei HB; Zhuo J; Sun XW; Pang K; Shao Y; Liang SJ; Cui D; Zhao FJ; Yu JJ; Xia SJ
Lasers Med Sci; 2014 May; 29(3):957-63. PubMed ID: 24026112
[TBL] [Abstract][Full Text] [Related]
15. Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of large volume prostates: preliminary 6-month safety and efficacy results of a prospective randomized trial.
Becker B; Herrmann TRW; Gross AJ; Netsch C
World J Urol; 2018 Oct; 36(10):1663-1671. PubMed ID: 29730838
[TBL] [Abstract][Full Text] [Related]
16. Five-year outcomes of thulium vapoenucleation of the prostate for symptomatic benign prostatic obstruction.
Gross AJ; Orywal AK; Becker B; Netsch C
World J Urol; 2017 Oct; 35(10):1585-1593. PubMed ID: 28405763
[TBL] [Abstract][Full Text] [Related]
17. Thulium laser vaporesection versus standard transurethral resection of the prostate: a randomized trial with transpulmonary thermodilution hemodynamic monitoring.
Yan H; Ou TW; Chen L; Wang Q; Lan F; Shen P; Li J; Xu JJ
Int J Urol; 2013 May; 20(5):507-12. PubMed ID: 23088252
[TBL] [Abstract][Full Text] [Related]
18. Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up.
Fu WJ; Hong BF; Yang Y; Zhang X; Gao JP; Zhang L; Wang XX
BJU Int; 2009 Feb; 103(3):352-6. PubMed ID: 18778340
[TBL] [Abstract][Full Text] [Related]
19. Thulium vapoenucleation of the prostate (ThuVEP) for prostates larger than 85 ml: long-term durability of the procedure.
Becker B; Orywal AK; Gross AJ; Netsch C
Lasers Med Sci; 2019 Oct; 34(8):1637-1643. PubMed ID: 30838464
[TBL] [Abstract][Full Text] [Related]
20. Two-micrometer thulium laser resection of the prostate-tangerine technique in benign prostatic hyperplasia patients with previously negative transrectal prostate biopsy.
Zhuo J; Wei HB; Zhang F; Liu HT; Zhao FJ; Han BM; Sun XW; ; Xia SJ
Asian J Androl; 2017; 19(2):244-247. PubMed ID: 26732107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
